Saturday, February 23, 2013 Friday, February 22, 2013- Feds probe J&J on recalled hip implant marketingAP (Fri, Feb 22)
- Left at the Altar: No Buyout For This Health Care Giantat Motley Fool (Fri, Feb 22)
- [video] Cramer: The Market Is Forgivingat CNBC (Fri, Feb 22)
- Why New Diabetes Drugs Won’t Dethrone Merck’s $5.7 Billion JanuviaYCharts (Fri, Feb 22)
- J&J Jury Reaches No Verdict After Fourth Day in Mesh Caseat Bloomberg (Fri, Feb 22)
- A Global Biotechnology Company in its 164th Yearat Motley Fool (Fri, Feb 22)
- News Summary: Feds probe J&J on hip implant salesAP (Fri, Feb 22)
- Avon CEO McCoy Embraces Technology to Reverse Profit Slumpat Bloomberg (Fri, Feb 22)
- UCB Seeks Cimzia Label ExpansionZacks (Fri, Feb 22)
- Biotech Investors: Please Don't Make This Mistakeat Motley Fool (Fri, Feb 22)
- What Are the Strongest and Weakest Names in Each Sector?Minyanville (Fri, Feb 22)
- Post-Earnings Sell-Off has Created a Buying Opportunity in This Stockat Motley Fool (Fri, Feb 22)
- Dendreon Earnings: An Early Lookat Motley Fool (Fri, Feb 22)
- Taking Added Advantage Of Reality: Johnson & Johnson, Pfizer, Qualcomm, Visa, Berkshire Hathawayat Forbes (Fri, Feb 22)
- Obamacare Boosts Health Sectorat TheStreet (Fri, Feb 22)
- MAKO Surgical Earnings: An Early Lookat Motley Fool (Fri, Feb 22)
- Is Johnson and Johnson Still an Outperform?at Wall St. Cheat Sheet (Fri, Feb 22)
- J&J Discloses Government Investigations of Hips, Meshat Bloomberg (Fri, Feb 22)
- JOHNSON & JOHNSON Files SEC form 10-K, Annual ReportEDGAR Online (Fri, Feb 22)
- J&J’s Toxicologist Says Metal From Recalled Hip Harmlessat Bloomberg (Fri, Feb 22)
Thursday, February 21, 2013Add JNJ News to My Yahoo!   | |
|
1.35%